On-line CME Webcast Discusses Skin Cancer

OSUWexnerbloglogo2014 On-line CME Webcast Discusses Skin Cancer. Skin cancer is the most common cancer in the United States. The good news is that we can usually prevent it. The bad news is that we usually don’t. On this CME webcast, we’re going to take a look at non-melanoma skin cancers with the two most common being basal cell carcinoma and squamous cell carcinoma. Joining our moderator in the studio is Mohs surgeon and Assistant Professor of Internal Medicine from the Division of Dermatology, Dr. David Carr.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the incidence, risk factors, clinical presentation, and treatment of Basal Cell Carcinoma (BCC); and DESCRIBE the incidence, risk factors, clinical presentation, and treatment of Squamous Cell Carcinoma (SCC).

You’ll also learn about the following:

  • The Ugly potential of non-melanoma skin cancers
  • Common anatomic locations
  • Sunscreen
  • Who to regularly screen for skin cancers and how to screen them
  • When to biopsy a suspected skin cancer
  • Treatment options for actinic keratosis
  • Mohs surgery

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Explore Webcast on Common Oral Diseases

OSUWexnerbloglogo2014 Explore Webcast Common Oral Diseases.  Oral pathology is just not something that many are taught a lot about in medical school and residency.  Nevertheless, your patients will often ask you about a new lesion in their mouth or you’ll see something on oral examination and just aren’t sure what exactly it is you’re looking at.  On this CME Webcast, we’re going to change all of that and give you a crash course in common oral diseases so that you’ll know what you are seeing when there is something just not right on the tongue, the lip, or the cheek.  In the studio with our moderator, Dr. Jim Allen, is Assistant Professor of Oral and Maxillofacial Pathology and Radiology from the Ohio State University College of Dentistry, Dr. Kristin McNamara. Also, from the OSU College of Dentistry, we have Professor of Oral and Maxillofacial Pathology, Dr. John Kalmar.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW a selection of common oral mucosal disorders, with emphasis on characteristic clinical findings, differential diagnosis, and management strategies; RECOGNIZE clinical features that distinguish traumatic ulcers from neoplastic ulcers
You’ll also learn about the following:

  • Routine oral examination for physicians
  • Aphthous ulcers myths and realities
  • Symptomatic management of aphthous ulcers
  • Follow up of patients with leukoplakia and erythroplakia
  • Approach to the recurrent traumatic oral ulcer
  • Management of oral burns
  • Oral hygiene 101
  • Fluoride and drinking water
  • Risk factors for squamous cell oral cancers
  • Non-squamous cell oral cancers

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Developments in Lung Cancer Treatment

OSUWexnerbloglogo2014 New Developments in Lung Cancer Treatment. Lung cancer now accounts for 14% of all cancers but it is the most common cause of cancer death, In fact, more people die each year from lung cancer than from colon cancer, breast cancer, and prostate cancer combined. The 5-year survival rate of lung cancer is only 18% but the good news is that we have a lot of new medications that are giving patients with lung cancer longer and better lives. On our CME webcast, to discuss new treatments in lung cancer, are two of Ohio State’s experts in the management of lung cancer. Joining our moderator, Dr. Jim Allen, we have Dr. Greg Otterson who is a Professor of Internal Medicine from the Division of Medical Oncology and Dr. Erin Bertino, an Assistant Professor of Internal Medicine, also from the Division of Medical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an understanding of the importance of genomic testing in the initial workup of patients with lung cancer. EXPLAIN the evolving role of immune mediated therapy in lung cancer; RECOGNIZE the clinical benefit for patients receiving targeted therapies; and DESCRIBE the patient characteristics commonly associated with actionable mutations in lung cancer.

You’ll also learn about the following:

  • The most fatal of all common cancers
  • Evolving chemotherapy treatment of lung cancer
  • Sub-classifying adenocarcinomas
  • Squamous cell lung cancer treatment
  • Large cell undifferentiated lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.